Kit for preparation of target radiopharmaceuticals and method of using it

Patent metadata

Field	Value
Publication number	US-9717808-B2
Application number	US-201414531127-A
Country	US
Kind code	B2
Filing date	Nov 3, 2014
Priority date	Oct 23, 2014
Publication date	Aug 1, 2017
Grant date	Aug 1, 2017

Abstract

The invention relates to a kit for preparation of target radiopharmaceuticals, a method of using the kit to prepare target radiopharmaceuticals and use of the target radiopharmaceuticals. The target radiopharmaceuticals comprise a radio-nuclear loading on liposome and inhibit the tumor growth and metastatic progression of head and neck cancer, lung cancer and brain cancer. The radiopharmaceuticals may be used for treating the mentioned cancers.

First claim

What is claimed is:

1. A method for preparing target radiopharmaceuticals, which comprises the steps of:
(1) mixing a vial B and a vial A and reacting the same at an appropriate temperature for an appropriate period, wherein the vial A contains lyophilized mixture of N,N-bis(2-mercaptoethyl)-N′,N′-diethyl-ethylenediamine(BMEDA), sodium gluconate, and stannous chloride, and the vial B contains an aqueous solution of radionuclide including 188 Re and/or 186 Re lyophilized, and wherein the lyophilized mixture is prepared by the steps of:
a) mixing BMEDA, sodium gluconate, and stannous chloride to produce a mixture;
b) freezing the mixture at −80° C. and flushing the same with N 2 gas under 0.120 mBar for 1 hour;
c) lyophilizing the mixture at −80° C. and flushing the same with N 2 gas under 0.120 mBar for 36 hours; and
c) lyophilizing the mixture at 18° C. and flushing the same with N 2 gas under the pressure of 0.120 mBar for 12 hours;

(2) adjusting the pH of the mixture obtained in step (1) in a range of 6˜7 by adding aqueous sodium hydroxide solution, and
(3) injecting the liposome solution in a vial C into the mixture obtained in step (2) and reacting at an appropriate temperature for an appropriate period to obtain a target pharmaceutical, i.e., 188 Re-and/or 186 Re-Liposome, wherein the vial C contains an aqueous liposome solution comprising phospholipid, cholesterol, and 1,2-distearoyl-sn-glycero-3- phosphoethanolamine-N-[maleimide (polyethylene glycol)-2000] (DSPE-PEG 2000) in a mole ratio of 30˜95:20˜45:3˜7.5.

2. The method according to claim 1 , wherein the step (1) is carried out in a temperature of from 4° C.˜110° C. for 30 minutes to 75 minutes.

3. The method according to claim 1 , the step (3) is carried out in a temperature of from 4° C.˜80° C. for 15 minutes to 60 minutes.

Assignees

• Iner Aec Executive Yuan

Inventors

• Chiu Shu-Pei
• Lin Bo-Sian
• Lin Liang-Ting
• Lee Yi-Jang
• Lee Te-Wei
• Huang Feng-Yun
• Lo Jem-Mau

Classifications

• A61P35/04

  specific for metastasis · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P1/02

  Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title

• A61K51/065 Primary

  conjugates with carriers being macromolecules · CPC title

• A61J1/05

  for collecting, storing or administering blood, plasma or medical fluids {(multiple bags systems for separating or storing blood components A61M1/0209); Infusion or perfusion containers} · CPC title